China TAVR & TMV Market Report 2023: Decline in Prices of Transcatheter Mitral Valve Procedures Presents Opportunities

Key Facts

• China TAVR market is expected to reach US$2.60 billion in 2027, growing at a CAGR of 55.91%, for the duration spanning 2023-2027.
• The TMV market in China is forecasted to reach US$1832.05 million in 2027, rising at a CAGR of 146.50%, for the time period of 2023-2027.
• Factors such as growing prevalence of aortic stenosis, rise in approval of new TAVR products, rise in geriatric population and rapid urbanization would drive the growth of the market.
• However, the market growth would be challenged by risks associated with TAVR procedures and challenge of patient selection in TMVI.

Click To Read Full Article